References (selection)
| Reference |
Detail |
URL |
Summary |
| Apoptosis / liver (in vitro) |
PMC4882837 (2016) |
PMC |
Apoptosis + inhibition of proliferation on hepatic tumor cells in culture. |
| Bladder (in vitro) |
Scientific Reports 2021; PMID 34799663 |
PubMed
|
Cytotoxicity, apoptosis and cycle arrest; selectivity vs. normal cells. |
| Breast/lung (in vitro) |
Pak J Pharm Sci 2019 |
PDF
|
IC 50 ~0.73 (MCF-7) / 1.10 mg/mL (A549). |
| Ovary (in vitro) |
Discover Oncology 2025 |
Article
|
Fulvic acid: decreases proliferation/migration/invasion via CYP1A1. |
| NSCLC (mouse) |
Heliyon 2023 |
PDF
|
Fulvic acids: tumor inhibition via COX-2 / PGE 2 / EP4. |
| Ovarian radioprotection (rat) |
PMID 26530234 |
PubMed
|
Tissue protection signal against radiation (animal model). |
| Osteosarcoma + chemo (rat) |
PMID 35957703 |
PubMed
|
Hepatorenal attenuation in co-administration; no human data. |
| DAPs: benefits/risks |
Int J Mol Sci 2021;22(23):13063 |
MDPI |
Overview of dibenzo-α-pyrones (urolithins vs alternariol: toxicological issues). |
| EU Contaminants Framework |
Regulation (EU) 2023/915 |
EUR-Lex |
Maximum levels of contaminants (including heavy metals) in foodstuffs. |
Warning
The information presented is for educational purposes only. It does not constitute medical advice, diagnosis, or treatment.
Before using any supplement or changing your lifestyle, please consult a healthcare professional .
In the context of cancer: coordination essential with the healthcare team .
